Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir

Pegylated interferon alpha (PEG-IFN α), a key component of chronic hepatitis C therapy, has been linked to the development of auto-antibodies and autoimmune disease. We report the first case of antimitochondrial antibody (AMA) seroconversion during PEG-INF α based therapy after liver.1–4 transplanta...

Full description

Bibliographic Details
Main Authors: Vladimir Marquez-Azalgara, Trana Hussaini, Siegfried R. Erb, Eric M. Yoshida
Format: Article
Language:English
Published: Elsevier 2014-09-01
Series:Annals of Hepatology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S166526811931258X